Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-15-067741

Chief Executive Officer bought 550 shares at $1.95 ($1,070)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-08-24 Purchase : show line 1 in the form +550 $1.95 $1,070 5,450 D
Open-market purchases · 550 sh · avg $1.95 · $1,070
Loading xslF345X03/doc4.xml…